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n8081 CorrelationBetweenOxidizedLowDensityLipoproteinsendCoronaryAtieryDiseasein Heart
TransplantPatienta
J. Vanhaecke, J.-M. Stassen, J. Van Cleemput, D. Cohen, P.Holvoet.
University of Leuven, Leuven, Belgium
The hypothesis that oxidized low density lipoproteins (OXLDL) play a role
in the pethogenesis of coronay artery disease in heart transplant patients
wae investigated. OXLDLwere measured with a monoclinal antibody (mAb-
4E6) based enzyme linked immunoeorbant assay (ELISA) that discriminated
OXLOL and native LDL 1000-fold. Blood samples were collected from 107
heart transplant patients, between 12 and 64 months affersurgery, and coro-
nary attery stenosis in these patients was assessed bycorona~ angiography.
Mean levels of OXLDL were significantly lower in patienta with angiograph-
icdly normal mronary arteries (grade O: 1.2 + 0.05 mg/dl; n = 79) than in
patients with mild (grade 1:2.1 +0.30 mg/dl; n = 18, p <0.001 vs grade O)or
severe (grade 11:3.2 +0.45 m@dl;n = 10; p < O.COIvs grade Oand p <0.05
vs grade 1)coronaty artery stenosis. Logistic regression analysis identified 4
(out of 18) parameters that were significantly and independently correlated
with poettransplant coronaty artery stenosis: plasma levels of OXLDL (p =
0.0001), length of follow-up (p = 0.0008), cytomegalovirus infection (p =
0.015) and donor age (p= 0.047). Coronary artery disease developed in 12
of 46 heart transplantation patients during a 3years follow-up period. Logistic
regression analysis revealed that plasma levels of OXLDL (p = 0.0076) and
age of donor (p= 0.035) predicted the progression of Coronav artery steno-
sis in these patienta. Conclusion: Plasma levels of OXLDLcorrelate with the
extent and the progression of posttrensplant coronary artery stenosis in heart
transplant patients.
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n8082 DonorHeartIachemicTimeiaa RiakFactorfor EarlyManifeatstionofAllograftCoronaryArtaryDisease
M. Nishimura, B. Radovancevic, W. Springer, E.K. Massin, O.H. Frazier.
TexasHearf Institute, Houston TX, USA
To test the hypothesis that early manifestation of ACAD is related to poorer
prognosis, we determined the mortality rates and dsk factors in patients
in whom ACAD was detected at 3 yeara or before (early ACAD) and at 3
yeara and after (late ACAD). Patients who underwent cardiac transplantation
between 1966 and 1990 (n = 110) were monitored with yearly coronav
arteriograms. The mean follow-up period was 73 months (13-116 months).
At 3 yeara after transplantation, 47 of 110 patients were diagnosed with
ACAD, and between 3 and 6 yeara after transplantation, an additional 22
patients were diagnosed with ACAD. The rate of mortality or graft loss from
ACAD at 2 yeara after diagnosis wee 57Y0for early ACAD and 16% for late
ACAD (p < 0.05). Multivariate analysis wasappliadtofactors associated with
the development of ACAD. The variables were: number of rejection episodes,
CMV infection, hyperlipidemia, diabetes mellitus, recipient age, donor age,
and donor iachemic time. The only significant predictor for the development
of early ACAD was a donor heart ischemic time longer than 160 min (p <
0.05), whereas the development of late ACAD was better predicted by other
factors, such as CMV infection, postoperative diabetes mellitus, and older
age of recipient. These data suggest that early ACAD is associated with a
higher mortality or graft loss rate and, further, that a donor heart with a long
ischemic time (>180 rein) is more likely to develop early ACAD. It appears
that ischemic injury plays a major role in development of early ACAD; thus
improvement in organ preservation and efforts to shorten the ischemic time
may provide additional protection for the development of early ACAD.
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n8083 BloodTroponin-TConcentratiOneCOrralStewithCoronaryArteryDiaeasesndAbnormslHemosteais,
FibrinolyaieandEndothelialActivationincardiac
AllogrstiRecipient
W.P. Faulk, R.J. Terry,C.A. Lsbarrere, D.R. Nelson, R.J. Kovacs,
Department of Research, Methodist Hospital, Indianapolis, Indiana, USA
Ourpublishad data from endomyoeardial biopsies haveshown that transplant-
induced coronaty artery disease (T-CAD) is preceded by these changes in
myocardial arteries and arterioles: (a) fibrin deposition, (b) depletion of tis-
sue plasminogen activator (tPA), and (c) endothelial activation. Although
these findings predict T-CAD, they require multiple biopsies. We have sought
serologic markers that predict T-CAD, similar to those that predict a risk for
spontaneous CAD. Unfortunately, biochemical risk factors for spontaneous
CAO do not apply to patients at risk for T-CAD. Our studies have focused
on serum concentrations of troponin-T (TnT), which measure the occurrence
and severity of myocardial infarctions. We asked if transplant recipients who
develop T-CAD have increased blood concentrations of TnT, and if these
concentrations correlate with biopsy findings of fibrin deposition, tPA deple-
tion and endothelial activation. We analyzed immunocyfochemical data from
111biopsies and multiple sample analysis of variance for TnTconcentrations
of 111 sera obtained at the time of biopsy from 46 allografl recipients. All
patients had coronary angiography. These experiments revealed highly sig-
nificant correlations of TnT with fibrin deposits (p = 0.001), tPAdepletion (p =
0.001), activation of atteriolar endothelium (p = 0.001), and CAD (p = 0.01).
Correlation with infiltrates of T-lymphocytes was not significant (p = 0.9). We
conclude that transplant recipients with elevated serum TnT concentrations
are at high risk for having T-CAD.
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H Tri9;YcerideLavelsCorrelstawithMicrovsac.larBut
NotEpicardialEndothelialDysfunctionAftarHeart
Tranaplantstion
S.M. Hollenberg, D. Bums, P.Tamburro, MR. Johnson, C. Easington,
M.R. Costanzo, J.E. Parrillo, L.W. Klein. Rush Medical College, Chicago, IL,
USA
Background: Endothelial dysfunction may represent an early marker forcoro-
nary allografl vasculopathy (CAV) following heart transplantation (TX). Lipid
levels correlate with endothelial dysfunction in native coronary arteries, and
triglyceride (TG) Ievelscorrelate with intimal thickening in TXpatients, but the
relationship between TG levels, endothelial dysfunction, and CAV following
TX has not been elucidated. Methods.’We used simultaneous intravascular
ultrasound (IVUS) and Doppler flow studies to distinguish epicardial from
microvascular endotheiial dysfunction find correlated dysfunction with lipid
levels. Diameter (IVUS) and velocity (Doppler wire) responses to intracoro-
nary adenosine (ADEN, 32 &g bolus) and acetylcholine (ACH, 54 #g over
2 rein) were evaluated in the LAD of 23 patients with normal coronary an-
giograms >1 yr after TX. Fasting lipid profiles were obtained at the time of
the study. Results: ACH induced vasodilation in 15 patients and paradoxical
vasoconstriction in 6. Epicardial area responses to ACH did not correlate with
lipid levels, but microvascular flow responses to ACH correlated negatively
with TG levels (r = 0.56, p = 0.01). When ACH flow responses were nor-
malized to ADEN responses, a significant correlation with TG levels was still
found (r= 0.50, p =0.03). Conclusions: Microvascular, but not epicardial, en-
dothelial dysfunction correlated with TG levels. These findings suggest that
lipids play a greater role in microvascular than epicardial endothelial dys-
function in CAV following heart transplantation, and reinforce the importance
of rigorous lipid control in thesepatients.
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~~ MechsnoenergeticEffectaof EMD~~~~~”nder
NormalandAcidoticConditionsin Isolated,Blood
PerfusedRabbitHssrts
T. Kameyama, Z. Chen, M.W. Watkins, M.M. LeWinter. The Univereifyof
Vermont,Burlington, ~ USA
Ca2+ sensitizing drugs may have reduced energy costs compared to con-
ventional agents and might be especially effective during acidosis when
myofilament Ca2+ desensitization occurs. We compared the effects of EMD
57033 (EMD), relatively selective Ca2+sensitizer, and dobutamine (OO@on
mechanoenergetics in an isovolumically contracting, rabbit heart preparation
under conditions of normal pH and acidosis. Myocardial 02 consumption
(VQ), the slope of the end-systolic pressure-volume relation (E~a.), force-
time integral (FTI) and pressure-volume area (PVA) were measured. l/slope
of the V02-PVA relation reflects the energy conversion efficiency (EFF) of
the contraefile machine~ and its V02 intercept (lNT) is a measure of non-
mechanical 02 consumption. At doses resulting in similar increases in E~m
(23-24%), EMD and DOB cause disparate effects on relaxation half-time
(30% increase with EMO vs 22% decrease with DOB) but similar effects on
